<DOC>
	<DOCNO>NCT01678924</DOCNO>
	<brief_summary>This safety efficacy study AGN-214868 patient postherpetic neuralgia ( PHN ) .</brief_summary>
	<brief_title>A Safety Efficacy Study AGN-214868 Patients With Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Postherpetic neuralgia pain present least 9 month Active herpes zoster skin rash Anticipated treatment postherpetic neuralgia first 3 month study , include oral topical medication , acupuncture , spinal cord stimulation , transcutaneous nerve stimulation ( TNS ) , trigger point injection Anticipated treatment pain medication treatment postherpetic neuralgia first 3 month study Use capsaicin treatment postherpetic neuralgia within 6 month , anticipate use first 3 month study Use botulinum toxin serotype reason within 6 month , anticipate use study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>